Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2009 | 10-2008 | 10-2007 | 12-2006 | 10-2006 | |
| Sales | 30 | 66 | 154 | 0 | 432 |
| Gross Profit | 30 | 66 | 154 | N/A | 432 |
| Operating Expenses | 5,017 | 5,518 | 4,757 | 2,077 | 3,481 |
| Operating Income | -4,987 | -5,452 | -4,603 | -2,077 | -3,049 |
| Interest Expense | 851 | 11 | 607 | 0 | 437 |
| Other Income | 5,845 | 47 | 2,756 | -4,121 | -2,711 |
| Pre-tax Income | 7 | -5,416 | -2,455 | -6,198 | -6,198 |
| Income Tax | -922 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 929 | -5,416 | -2,455 | -6,198 | -6,198 |
| Net Income | $929 | $-5,416 | $-2,455 | $-6,198 | $-6,198 |
| EPS Basic Total Ops | 0.01 | -0.05 | -0.05 | N/A | -0.16 |
| EPS Basic Continuous Ops | 0.01 | -0.05 | -0.05 | N/A | -0.16 |
| EPS Diluted Total Ops | 0.01 | -0.05 | -0.05 | N/A | -0.16 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | -0.05 | N/A | -0.16 |
| EBITDA(a) | $-4,691 | $-5,254 | $-4,339 | $-2,077 | $-2,905 |